Table 2. OS-related factors in BRCA.
Characteristics | Total (N) | HR (95% CI) | P-value | HR (95% CI) | P-value |
T stage | 1083 | 0.004 | |||
T1 | 277 | Reference | Reference | ||
T2 | 631 | 1.336 (0.890–2.006) | 0.162 | 0.928 (0.576–1.494) | 0.758 |
T3 | 140 | 1.551 (0.921–2.612) | 0.099 | 1.091 (0.580–2.052) | 0.787 |
T4 | 35 | 3.759 (1.959–7.213) | <0.001 | 1.902 (0.877–4.124) | 0.104 |
N stage | 1067 | <0.001 | |||
N0 | 516 | Reference | Reference | ||
N1 | 358 | 1.947 (1.322–2.865) | <0.001 | 1.591 (1.023–2.476) | 0.039 |
N2 | 116 | 2.522 (1.484–4.287) | <0.001 | 2.888 (1.583–5.269) | <0.001 |
N3 | 77 | 4.191 (2.318–7.580) | <0.001 | 3.779 (1.714–8.329) | <0.001 |
M stage | 925 | <0.001 | |||
M0 | 905 | Reference | Reference | ||
M1 | 20 | 4.266 (2.474–7.354) | <0.001 | 1.475 (0.726–2.998) | 0.282 |
PR status | 1037 | 0.191 | |||
Negative | 342 | Reference | |||
Indeterminate | 4 | 0.825 (0.113–6.028) | 0.850 | ||
Positive | 691 | 0.729 (0.521–1.020) | 0.065 | ||
ER status | 1038 | 0.005 | |||
Negative | 240 | Reference | Reference | ||
Indeterminate | 2 | 13.090 (3.128–54.779) | <0.001 | 7.193 (0.892–58.002) | 0.064 |
Positive | 796 | 0.709 (0.493–1.019) | 0.063 | 0.521 (0.290–0.933) | 0.028 |
HER2 status | 729 | 0.095 | |||
Negative | 560 | Reference | |||
Indeterminate | 12 | 0.000 (0.000–Inf) | 0.994 | ||
Positive | 157 | 1.593 (0.973–2.609) | 0.064 | ||
PAM50 | 1086 | 0.024 | |||
Normal | 40 | Reference | Reference | ||
LumA | 563 | 0.659 (0.302–1.438) | 0.295 | 0.928 (0.326–2.636) | 0.888 |
LumB | 206 | 1.101 (0.486–2.495) | 0.818 | 1.187 (0.404–3.490) | 0.755 |
Her2 | 82 | 1.498 (0.621–3.614) | 0.369 | 1.253 (0.385–4.073) | 0.708 |
Basal | 195 | 0.847 (0.371–1.935) | 0.694 | 0.947 (0.303–2.958) | 0.925 |
KLRB1 | 1086 | <0.001 | |||
Low | 543 | Reference | Reference | ||
High | 543 | 0.550 (0.396–0.763) | <0.001 | 0.533 (0.361–0.787) | 0.002 |
Abbreviations: BRCA: breast invasive carcinoma; OS: overall survival.